A Comprehensive Review on Berberis Aristata DC: Phytochemistry, Pharmacology, and Therapeutic Potential

Abstract

Berberis aristata DC, commonly known as Indian barberry or Daruharidra, is a medicinal plant extensively used in traditional systems of medicine such as Ayurveda, Siddha, and Unani. The plant is particularly valued for its rich content of isoquinoline alkaloids, of which berberine is the most prominent and pharmacologically active constituent. In recent years, scientific research has increasingly focused on berberine and Berberis aristata due to their wide spectrum of pharmacological activities, including antidiabetic, hypolipidemic, antimicrobial, antiinflammatory, hepatoprotective, neuroprotective, and anticancer effects.

This literature review aims to provide a comprehensive and systematic evaluation of the botanical characteristics, phytochemical composition, pharmacological properties, mechanisms of action, clinical evidence, safety profile, and future prospects of Berberis aristata, with particular emphasis on berberine.

Although berberine demonstrates significant therapeutic potential across multiple disease conditions, its clinical application is limited by poor oral bioavailability and pharmacokinetic challenges. Recent advancements in formulation strategies and drug delivery systems aimed at enhancing berberine absorption are also discussed. Overall, Berberis aristata represents a promising medicinal plant with potential applications in modern pharmacotherapy; however, further well-designed clinical studies and standardization efforts are required to establish its efficacy and safety conclusively.